Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Current Pharmaceutical Design, 26 , 12771285
Health Canada spokesperson MariePier Burelle said the regulator is on track to meet review targets for generic semaglutide drug submissions, with an initial review timeline of about six months, not including additional time for companies to respond to data requests
A supplier advertising "pharmaceutical-grade retatrutide" for $99 per vial is not selling what they claim
Product sold online is unregulated, with purity and dosing unverifiable
US$ 20.19
US$ 29.67
US$ 23.60
US$ 25.76
US$ 28.47
US$ 29.65
US$ 26.69
